Author(s)

Sow Djiby^*, Djiba Boundia, Ndour Michel Assane, Diedhiou Demba, Dieng Mouhamed, Diallo Ibrahima Mané, Fall Ndiouga, Gueye Khoudia, Gadji Fatou Kiné, Sarr Anna, Diop Said Nourou, Ndour Mbaye Maimouna

Department of Internal Medicine and Medical Specialties, Hôpital Abass Ndao, Dakar, Senegal.

Introduction: Macroangiopathy plays an important role, with a high prevalence of morbidity and mortality in diabetic patients. The aim was to study the epidemiological, clinical, paraclinical, therapeutic and evolutionary profile of macroangiopathy in diabetic patients in the internal medicine department of the Abass Ndao hospital. Patients and methods: This was a descriptive and analytical cross-sectional study. Our investigations were recruited over a 7-year period (January 1, 2016 to December 31, 2022). Results: Three hundred and fifty-nine (359) patients (10.22%) were enrolled. The mean age was 62.83 years, with extremes ranging from 17 to 98 years. The [60 - 69] age group was more representative (37.32%). Women accounted for 180 cases (50.1%), with a sex ratio (m/f) of 0.99. The average duration of diabetes was 11.86 years. Average consultation time was 38.07 days, with extremes ranging from 1 to 368 days. Average hospital stay was 7.65 days. Inaugural diabetes was noted in 12 cases (3.34%). Type 2 diabetes accounted for 95.82% (n = 344) of patients. Hypertension was present in 150 patients (41.8%). Patients with 2 risk factors accounted for 173 cases (48.18%). Nineteen patients had already had a stroke (5.29% of cases). Fourteen (14) patients (4.2%) were amputees. Obliterative arteriopathy of the lower limbs (AOMI) was noted in 193 patients (54%). Stroke was noted in 101 patients (28%). Ischemic heart disease (IHD) was noted in 38 patients (11%). AOMI was more common in males (110 patients, 57%) than in females (43%). Seventy-three (73) patients (20.3%) died. Predictors of death were age over 60 and the existence of more than two cardiovascular risk factors. Conclusion: Diabetic macroangiopathy is a major cause of morbidity and mortality. The development and implementation of a prevention and management program is essential.

Macroangiopathy, Diabetes, Risk Factors, Senegal

Djiby, S. , Boundia, D. , Assane, N. , Demba, D. , Mouhamed, D. , Mané, D. , Ndiouga, F. , Khoudia, G. , Kiné, G. , Anna, S. , Nourou, D. and Maimouna, N. (2024) Diabetic Macroangioapathy at the Internal Medicine Department of the Abass Ndao Hospital Center (About 359 Cases). Journal of Diabetes Mellitus, 14, 1-12. doi: 10.4236/jdm.2024.141001.